Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 5/2007

01-05-2007 | Case Report

A hidradenitis suppurativa related SAPHO case associated with features resembling spondylarthropathy and proteinuria

Authors: Özden Özyemisci-Taskiran, Nesrin Bölükbasi, Feride Gögüs

Published in: Clinical Rheumatology | Issue 5/2007

Login to get access

Abstract

We present a 53-year-old man with synovitis–acne–palmoplantar pustulosis–hyperosteosis–osteitis (SAPHO) syndrome who is HLA-B27 positive with a history of uveitis and complicated by proteinuria and osteoporosis. Interesting, yet unreported features of SAPHO syndrome and the etiology of proteinuria are further discussed.
Literature
1.
Hayem G, Bouchaud-Chabot A, Benali K, Roux S, Palazzo E, Silbermann-Hoffman O et al (1999) SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 29:159–171PubMedCrossRef
2.
Bolukbas N, Bolukbas S, Erel A, Tali ET (1996) Sapho syndrome associated with acne fulminans and prominent acromioclavicular joint involvement. Scand J Rheumatol 25:180–182PubMed
3.
Deltombe T, Nisolle JF, Boutsen Y, Gustin T, Gilliard C, Hanson P (1999) Cervical spinal cord injury in sapho syndrome. Spinal Cord 37:301–304PubMedCrossRef
4.
Legoupil N, Revelon G, Allain J, Voisin MC, Rahmouni A, Chevalier X et al (2001) Iliac vein thrombosis complicating SAPHO syndrome: MRI and histologic features of soft tissue lesions. Joint Bone Spine 68:79–83PubMedCrossRef
5.
Cunningham T, Farrell J, Veale D, Fitzgerald O (1993) Anterior mediastinal fibrosis with superior vena caval obstruction complicating the synovitis–acne–pustulosis–hyperostosis–osteomyelitis syndrome. Br J Rheumatol 32:408–410PubMedCrossRef
6.
7.
Bohn J, Svensson H (2001) Surgical treatment of hidradenitis suppurativa. Scand J Plast Reconstr Surg Hand Surg 35:305–309PubMedCrossRef
8.
Toussirot E, Dupond JL, Wendling D (1997) Spondylodiscitis in SAPHO syndrome. A series of eight cases. Ann Rheum Dis 56:52–58PubMedCrossRef
9.
Valentin R, Gurtler KF, Schaker A (1997) Renal amyloidosis and renal failure—a novel complication of the SAPHO syndrome. Nephrol Dial Transplant 12:2420–2423PubMedCrossRef
10.
Caravatti M, Wiesli P, Uebelhart D, Germann D, Welzl-Hinterkorner E, Schulthess G (2002) Coincidence of Behcet’s disease and SAPHO syndrome. Clin Rheumatol 21:324–327PubMedCrossRef
11.
Leachman SA, Insogna KL, Katz L, Ellison A, Milstone LM (1999) Bone densities in patients receiving isotretinoin for cystic acne. Arch Dermatol 135:961–965PubMedCrossRef
12.
Margolis DJ, Attie M, Leyden JJ (1996) Effects of isotretinoin on bone mineralization during routine therapy with isotretinoin for acne vulgaris. Arch Dermatol 132:769–774PubMed
13.
Coe FL, Brenner BM (1998) Approach to the patient with diseases of the kidneys and urinary tract. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL (eds) Harrison’s principles of internal medicine. McGraw-Hill, New York, pp 1495–1498
14.
van Oers JA, de Leeuw J, van Bommel EF (2000) Nephrotic syndrome associated with isotretinoin. Nephrol Dial Transplant 15:923–924PubMedCrossRef
15.
Pavese P, Kuentz F, Belleville C, Rouge PE, Elsener M (1997) Renal impairment induced by isotretinoin. Nephrol Dial Transplant 12:1299PubMedCrossRef
Metadata
Title
A hidradenitis suppurativa related SAPHO case associated with features resembling spondylarthropathy and proteinuria
Authors
Özden Özyemisci-Taskiran
Nesrin Bölükbasi
Feride Gögüs
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 5/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0199-5

Other articles of this Issue 5/2007

Clinical Rheumatology 5/2007 Go to the issue

Case Report

Lumbosacral pain: chordoma—a diagnosis not to forget

Case Report

Hemophagocytic syndrome as one of main manifestations in untreated systemic lupus erythematosus: two case reports and literature review

Original Article

The evaluation of quality of life in fibromyalgia syndrome: a comparison with rheumatoid arthritis by using SF-36 Health Survey

Review Article

Measuring quality of life in rheumatic conditions

Case Report

How could we make a diagnosis of Wegener’s granulomatosis?

Case Report

Polymyositis associated with focal mesangial proliferative glomerulonephritis with depositions of immune complexes
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits